Epistaxis (Nosebleeds) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.
Condition: Hemorrhagic Hereditary Telangiectasia Interventions: Drug: Nintedanib 150 mg and 100 mg soft capsules; Drug: Oral treatment of placebo soft capsule Sponsor: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2019 Category: Research Source Type: clinical trials
